首页> 外文OA文献 >Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

【2h】

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

机译：关于Doravirine的药物，临床和抗性信息，一种用于治疗HIV-1感染的新型非核苷逆转录酶抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hanh Thi Pham; Meng A Xiao; Miguel AV Principe; Alexander Wong; Thibault Mesplède;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection [J] . Talwani R., Temesgen Z. Drugs of today: Medicamentos de actualidad . 2020,第2期

机译：Doravirine：一种新的非核苷逆转录酶抑制剂，用于治疗HIV感染
2. Efficacy and safety of lersivirine versus etravirine for the treatment of HIV-1 infection in patients with prior non-nucleoside reverse transcriptase inhibitor (NNRTI) use and evidence of NNRTI resistance: a randomized phase 2B trial. [J] . Edwin DeJesus, Gerd F?tkenheuer, Catherine Orrell, HIV clinical trials . 2014,第5期

机译：lersivirine与etravirine在先前使用非核苷类逆转录酶抑制剂（NNRTI）的患者中治疗HIV-1感染的有效性和安全性以及NNRTI耐药性的证据：一项2B期随机试验。
3. Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors. [J] . Wallis CL, Mahomed I, Morris L, Journal of Virological Methods . 2005,第2期

机译：评估寡核苷酸连接测定法，以检测对核苷类逆转录酶抑制剂和非核苷类逆转录酶抑制剂具有高水平耐药性的HIV-1亚型C个体中的突变。
4. A Novel Detection of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for HIV-1 with AlGaN/GaN High Electron Mobility Transistors [C] . Yen-Wen Kang, Geng-Yen Lee, Jen-Inn Chyi, Symposium on wide bandgap semiconductor materials and devices;Meeting of the Electrochemical Society . 2013

机译：AlGaN / GaN高电子迁移率晶体管对HIV-1的非核苷逆转录酶抑制剂（NNRTIs）的新型检测
5. Biochemical characterization of human immunodeficiency virus type 1 reverse transcriptase mutants to non-nucleoside reverse transcriptase inhibitors [D] . Domaoal, Robert A. 2005

机译：人类免疫缺陷病毒1型逆转录酶突变体对非核苷类逆转录酶抑制剂的生化特性
6. Pharmaceutical clinical and resistance information on doravirine a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection [O] . Hanh Thi Pham, Meng A Xiao, Miguel AV Principe, 2020

机译：doravirine的药物临床和耐药性信息一种用于治疗HIV-1感染的新型非核苷类逆转录酶抑制剂
7. Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations [O] . Alexander Wong, Deborah Goldstein, Josep Mallolas, 2019

机译：含有HIV-1和透射的壬核苷逆转录酶抑制剂抗性突变治疗 - 幼稚嘧啶/胞藤/替诺夫韦富马酸薄荷（DOR / 3TC / TDF）的疗效和安全性

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

著录项

引文网络

相似文献

相关主题

期刊订阅